Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "The pending allowance of the ‘336 patent claims may impact settlement"

"What scares me is why RG and his charts keep telling us they expect the MMP revenues to become a small part of our total revenues. Has he and the BOD made arrangements to sell our MMP patent revenue rights for peanuts?????? Like a steady return of say 20 million net net net a year versus our current fluctuating revenues."

Maybe he didn't expect us to come out of reexams so well. Since they apparently believe in accurate revenue projects (ie restating PDSG) perhaps they should revisit that.

Share
New Message
Please login to post a reply